论文部分内容阅读
目的 评价CT导向下经皮穿刺无水乙醇注射治疗肾囊肿的临床应用价值。资料与方法 16例 2 4个肾囊肿 ,其中单纯性肾囊肿 10例 ,肾盂旁囊肿 2例 ,多囊肾 4例。在CT导向下行穿刺无水乙醇硬化治疗 ,分析其并发症 ,并追踪观察其疗效。结果 16例中 ,2 4个囊肿顺利完成穿刺硬化治疗 ,无严重并发症发生 ,对 18个囊肿术后追踪观察 3个月～ 1年 ,0～Ⅲ级囊肿疗效个数分别为 1(5 .6 %)、2 (11.1%)、3(16 .7%)和 12 (6 6 .7%) ,临床症状缓解率为 81.8%(9/ 11)。结论 CT导向下经皮肾囊肿穿刺无水乙醇硬化治疗是一种安全有效的治疗方法。
Objective To evaluate the clinical value of CT guided percutaneous ethanol injection in the treatment of renal cysts. Materials and Methods 16 cases of 24 renal cysts, including simple renal cysts in 10 cases, 2 cases of psoas cyst, polycystic kidney in 4 cases. Guided by CT guided percutaneous ethanol dehydration therapy, analyze its complications, and follow-up observation of its efficacy. Results Of the 16 cases, 24 cases of cyst successfully completed puncture and sclerotherapy without serious complications. The follow-up of 18 cysts was observed for 3 months to 1 year. The number of 0 ~ Ⅲ cysts was 1 (5). 6%), 2 (11.1%), 3 (16.7%) and 12 (6.6%). The clinical symptom remission rate was 81.8% (9/11). Conclusion CT-guided percutaneous nephroureterectomy is an effective and safe method for the treatment of patients with alcohol-induced cirrhosis.